L12.31

Epidermolysis bullosa due to drug

Billable / specific

L12.31 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.

Excludes1

Not coded here — never report together with this code.

epidermolysis bullosa (congenital) (Q81.-) (from L12.3)
benign familial pemphigus [Hailey-Hailey] (Q82.8) (from L12)
staphylococcal scalded skin syndrome (L00) (from L12)
toxic epidermal necrolysis [Lyell] (L51.2) (from L12)
herpes gestationis (O26.4-) (from L12)
impetigo herpetiformis (L40.1) (from L12)

Not included here — may be reported together when both conditions exist.

certain conditions originating in the perinatal period (P04-P96) (from L12)
certain infectious and parasitic diseases (A00-B99) (from L12)
complications of pregnancy, childbirth and the puerperium (O00-O9A) (from L12)
congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) (from L12)
endocrine, nutritional and metabolic diseases (E00-E88) (from L12)
lipomelanotic reticulosis (I89.8) (from L12)
neoplasms (C00-D49) (from L12)
symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) (from L12)
systemic connective tissue disorders (M30-M36) (from L12)
viral warts (B07.-) (from L12)

Add a code to identify the following, if applicable.

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)